TABLE 3.

Proportion of age, sex, and diagnostic codes in relation to the results of NOTE.

Drug	Variable	Effectiveness of the NOTE score a						Statistics b
		Total	N/A c	Intolerance	Improved	No change	Worsen	p-value
SSRI	Diagnosis code, n (%)							0.70
	AD d	73 (100%)	3 (4.1%)	4 (5.5%)	50 (68%)	9 (12%)	7 (9.6%)
	VD d	42 (100%)	1 (2.4%)	3 (7.1%)	27 (64%)	8 (19%)	3 (7.1%)
	AD + VD	20 (100%)	1 (5.0%)	1 (5.0%)	16 (80%)	2 (10%)	0 (0%)
	Others	90 (100%)	1 (1.1%)	9 (10%)	63 (70%)	9 (10%)	8 (8.9%)
	Sex, n (%)							0.20
	Woman	117 (100%)	4 (3.4%)	11 (9.4%)	80 (68%)	10 (8.5%)	12 (10%)
	Man	108 (100%)	2 (1.9%)	6 (5.6%)	76 (70%)	18 (17%)	6 (5.6%)
	Age at the start of the medication, mean (SD)							0.45
		73 (9.7)	70 (10.4)	72 (12.7)	73 (9.2)	76 (8.6)	72 (12.4)
	Total, n (%)
		225 (100%)	6 (2.7%)	17 (7.6%)	156 (69%)	28 (12%)	18 (8.0%)
CEI	Diagnosis code, n (%)							0.66
	AD	54 (100%)	3 (5.6%)	2 (3.7%)	15 (28%)	19 (35%)	15 (28%)
	VD	13 (100%)	1 (7.7%)	2 (15%)	3 (23%)	4 (31%)	3 (23%)
	AD + VD	13 (100%)	0 (0%)	1 (7.7%)	6 (46%)	4 (31%)	2 (15%)
	Others	35 (100%)	3 (8.6%)	7 (20%)	7 (20%)	13 (37%)	5 (14%)
	Sex, n (%)							0.20
	Woman	55 (100%)	6 (11%)	3 (5.5%)	13 (24%)	20 (36%)	13 (24%)
	Man	60 (100%)	1 (1.7%)	9 (15%)	18 (30%)	20 (33%)	12 (20%)
	Age at the start of the medication, mean (SD)							0.30
		74 (8.8)	79 (7.7)	77 (10.1)	73 (9.7)	74 (8.5)	73 (7.6)
	Total, n (%)
		115 (100%)	7 (6.1%)	12 (10%)	31 (27%)	40 (35%)	25 (22%)

^a SSRI, psychiatric NOTE score; CEI, cognitive NOTE score.

^b Type II likelihood ratio test on the multinomial model.

^c N/A, prioritized comment on the treatment effect not available.

^d AD, Alzheimer’s disease; VD, vascular dementia.